ENASIDENIB vs ENCORAFENIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ENASIDENIB vs ENCORAFENIB: Safety Overview
| Metric | ENASIDENIB | ENCORAFENIB |
|---|---|---|
| Total FAERS Reports | 3,704 | 8,554 |
| Deaths Reported | 967 | 1,397 |
| Death Rate | 26.1% | 16.3% |
| Hospitalizations | 1,143 | 2,334 |
| Average Patient Age | 70.3 yrs | 64.4 yrs |
| % Female Patients | 43.6% | 50.9% |
| FDA Approval Date | Aug 1, 2017 | Jun 27, 2018 |
| Manufacturer | Celgene Corporation | Array BioPharma Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Discontinued |